Previsioni di mercato per le organizzazioni di vendita a contratto di farmaci per il Sud e Centro America fino al 2030 - Analisi regionale - per servizi (servizi commerciali e servizi non commerciali), moduli (moduli sindacati e moduli dedicati), area terapeutica (disturbi cardiovascolari, oncologia, disturbi metabolici, neurologia, Malattie ortopediche, malattie infettive e altre) e utente finale (aziende biofarmaceutiche e aziende farmaceutiche)

BMIRE00030180 | Pages: 73 | Pharmaceuticals | May 2024 | Type: Regional | Status: Published
Si prevede che il mercato delle organizzazioni di vendita farmaceutica a contratto in Sud e Centro America crescerà da 344,44 milioni di dollari nel 2022 a 621,93 milioni di dollari entro il 2030. Si stima che crescerà a un CAGR del 7,7% dal 2022 al 2030. di Telemedicina e Remote Detailing guidano il mercato delle organizzazioni di vendita a contratto farmaceutiche in Sud e Centro America

Il crescente utilizzo della telemedicina e del remote Detailing porta a nuove opportunità per il mercato delle organizzazioni di vendita a contratto farmaceutiche (CSO). L’influenza trasformativa delle tecnologie sanitarie digitali ha ridefinito le interazioni paziente-medico e rivoluzionato le dinamiche delle vendite farmaceutiche. Con la sua capacità di facilitare consultazioni e impegni virtuali, la telemedicina crea un terreno fertile affinché le organizzazioni della società civile possano adattarsi e innovare. Il remote detailing, che prevede l’utilizzo di canali digitali per comunicare informazioni sui prodotti e coinvolgere gli operatori sanitari, diventa una via strategica per le organizzazioni della società civile per estendere la propria portata. Questo cambiamento strategico evidenzia l\'approccio proattivo dell\'industria farmaceutica nell\'affrontare la complessità del mercato. Collaborando con le organizzazioni della società civile, queste aziende possono accedere a personale di vendita specializzato, sfruttando competenze esterne per aumentare la penetrazione nel mercato e migliorare l\'efficacia delle vendite. Attraverso questo modello collaborativo, le aziende farmaceutiche possono ottimizzare le proprie operazioni e concentrarsi su capacità chiave come la ricerca e lo sviluppo, utilizzando al contempo la conoscenza specifica delle organizzazioni della società civile per aumentare la commerciabilità dei propri prodotti. La crescente cooperazione tra aziende farmaceutiche e organizzazioni della società civile dimostra una dedizione all’adattamento e una profonda comprensione delle dinamiche di sviluppo all’interno di un’industria farmaceutica molto competitiva. Mostra anche una comprensione sfumata dell’ottimizzazione delle risorse. Questa partnership reciprocamente vantaggiosa rende possibile la massimizzazione dei ricavi e colloca strategicamente le aziende farmaceutiche in un mercato in cui l’adattabilità e le strategie di mercato mirate sono essenziali per il successo a lungo termine.

Panoramica del mercato delle organizzazioni di vendita a contratto per prodotti farmaceutici in America meridionale e centrale

Il mercato delle organizzazioni di vendita a contratto per prodotti farmaceutici in America meridionale e centrale è segmentato in Brasile, Argentina e nel resto dell\'America meridionale e centrale. Il mercato dell\'organizzazione delle vendite farmaceutiche a contratto nell\'America meridionale e centrale sta vivendo una crescita significativa a causa dell\'espansione del mercato farmaceutico, insieme alla crescente necessità di soluzioni di vendita economicamente vantaggiose. Inoltre, le economie di molti paesi della regione sono in difficoltà a causa della crescente prevalenza di malattie croniche e dell’invecchiamento della popolazione. Il cambiamento dei modelli di stile di vita sta influenzando anche il settore sanitario di questi paesi, determinando una maggiore domanda di prodotti farmaceutici. Le aziende farmaceutiche si rivolgono a organizzazioni di vendita a contratto per promuovere e distribuire efficacemente i propri prodotti in questo mercato competitivo. Inoltre, le persone nell’America meridionale e centrale stanno diventando sempre più preoccupate per l’assistenza sanitaria e sono disposte a spendere somme maggiori in prodotti farmaceutici a causa del crescente reddito disponibile. Le organizzazioni di vendita a contratto sono fondamentali per raggiungere un segmento di consumatori così in espansione. Inoltre, i governi stanno attuando politiche per migliorare l’accesso all’assistenza sanitaria e ridurre i costi sanitari. Tali cambiamenti normativi e riforme nel settore sanitario alimentano la domanda dei servizi forniti da queste organizzazioni, avvantaggiando così il mercato delle organizzazioni di vendita a contratto farmaceutiche nel Sud e Centro America.

Entrate e previsioni del mercato delle organizzazioni di vendita a contratto farmaceutiche del Sud e America Centrale fino al 2030 (milioni di dollari)

Segmentazione del mercato delle organizzazioni di vendita a contratto farmaceutiche dell\'America del Sud e Centro

Il mercato delle organizzazioni di vendita a contratto farmaceutiche dell\'America del Sud e Centro è segmentato in servizi, moduli, area terapeutica, utente finale e paese.

Sulla base dei servizi, il mercato delle organizzazioni di vendita farmaceutica a contratto in Sud e Centro America è suddiviso in servizi commerciali e servizi non commerciali. Nel 2022, il segmento dei servizi commerciali deteneva una quota maggiore del mercato delle organizzazioni di vendita a contratto farmaceutiche in Sud e Centro America.

Sulla base dei moduli, il mercato delle organizzazioni di vendita a contratto farmaceutiche in Sud e Centro America è suddiviso in moduli sindacati e moduli dedicati. Nel 2022, il segmento dei moduli sindacati deteneva una quota maggiore del mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Sud e Centro America.

In base all\'area terapeutica, il mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Sud e Centro America è segmentato in disturbi cardiovascolari, oncologia, disturbi metabolici , neurologia, malattie ortopediche, malattie infettive e altri. Il segmento oncologico deteneva la quota maggiore del mercato delle organizzazioni di vendita a contratto farmaceutiche in Sud e Centro America nel 2022.

In base all\'utente finale, il mercato delle organizzazioni di vendita a contratto farmaceutiche in Sud e Centro America è suddiviso in società biofarmaceutiche e aziende farmaceutiche. Nel 2022, il segmento delle aziende farmaceutiche deteneva una quota maggiore del mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Sud e Centro America.

In base al paese, il mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Sud e Centro America è segmentato in Brasile, Argentina e resto del mondo. Sud e Centro America. Il Brasile ha dominato il mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Sud e Centro America nel 2022.

IQVIA Holdings Inc, Pfizer Inc, Sales Focus Inc e Syneos Health Inc sono alcune delle aziende leader che operano nelle organizzazioni di vendita a contratto di prodotti farmaceutici in Sud e Centro America mercato.

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 South & Central America PEST Analysis

5. South & Central America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - South & Central America Analysis

6.1 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopaedic Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 South & Central America Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1 Brazil

11.1.1.1 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.5 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.2 Argentina

11.1.2.1 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.2 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.2.3 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.2.4 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.2.5 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.3 Rest of South & Central America

11.1.3.1 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.3.2 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.3.3 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.3.4 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.3.5 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 IQVIA Holdings Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Syneos Health Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sales Focus Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

 

 

 

List of Tables

Table 1. South & Central America Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 15. Glossary of Terms, South & Central America Pharmaceutical Contract Sales Organizations Market

 

List of Figures

Figure 1. South & Central America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. South & Central America - PEST Analysis

Figure 3. South & Central America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. South & Central America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 24. South & Central America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. IQVIA Holdings Inc

 

2. Pfizer Inc

3. Sales Focus Inc

4. Syneos Health Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Pharmaceutical Contract Sales Organizations Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440